Vanguard Group’s HOOKIPA Pharma HOOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-300,819
| Closed | -$378K | – | 4384 |
|
|
2025
Q2 | $378K | Hold |
300,819
| – | – | ﹤0.01% | 3984 |
|
|
2025
Q1 | $325K | Buy |
300,819
+87,597
| +41% | +$144K | ﹤0.01% | 3981 |
|
|
2024
Q4 | $429K | Hold |
213,222
| – | – | ﹤0.01% | 3980 |
|
|
2024
Q3 | $917K | Buy |
213,222
+1,175
| +0.6% | +$6.21K | ﹤0.01% | 3800 |
|
|
2024
Q2 | $1.25M | Buy |
212,047
+205
| +0.1% | +$1.63K | ﹤0.01% | 3716 |
|
|
2024
Q1 | $1.51M | Buy |
211,842
+362
| +0.2% | +$2.58K | ﹤0.01% | 3680 |
|
|
2023
Q4 | $1.71M | Buy |
211,480
+29,731
| +16% | +$164K | ﹤0.01% | 3657 |
|
|
2023
Q3 | $1.12M | Sell |
181,749
-409
| -0.2% | -$3K | ﹤0.01% | 3796 |
|
|
2023
Q2 | $1.6M | Buy |
182,158
+6,950
| +4% | +$77.2K | ﹤0.01% | 3736 |
|
|
2023
Q1 | $1.29M | Hold |
175,208
| – | – | ﹤0.01% | 3838 |
|
|
2022
Q4 | $1.42M | Sell |
175,208
-1,154
| -0.7% | -$12.5K | ﹤0.01% | 3792 |
|
|
2022
Q3 | $2.36M | Buy |
176,362
+11,189
| +7% | +$172K | ﹤0.01% | 3683 |
|
|
2022
Q2 | $2.69M | Buy |
165,173
+53,286
| +48% | +$882K | ﹤0.01% | 3677 |
|
|
2022
Q1 | $2.55M | Buy |
111,887
+20,631
| +23% | +$370K | ﹤0.01% | 3863 |
|
|
2021
Q4 | $2.13M | Buy |
91,256
+86
| +0.1% | +$3.46K | ﹤0.01% | 4011 |
|
|
2021
Q3 | $5.37M | Buy |
91,170
+1,055
| +1% | +$76.5K | ﹤0.01% | 3611 |
|
|
2021
Q2 | $8.26M | Buy |
90,115
+1,247
| +1% | +$166K | ﹤0.01% | 3310 |
|
|
2021
Q1 | $12M | Buy |
88,868
+14,822
| +20% | +$1.79M | ﹤0.01% | 3057 |
|
|
2020
Q4 | $8.21M | Buy |
74,046
+10,764
| +17% | +$1.16M | ﹤0.01% | 3094 |
|
|
2020
Q3 | $5.99M | Buy |
63,282
+17,746
| +39% | +$1.81M | ﹤0.01% | 3057 |
|
|
2020
Q2 | $5.29M | Sell |
45,536
-1,655
| -4% | -$161K | ﹤0.01% | 3068 |
|
|
2020
Q1 | $3.9M | Buy |
47,191
+2,726
| +6% | +$299K | ﹤0.01% | 3075 |
|
|
2019
Q4 | $5.44M | Buy |
44,465
+31,326
| +238% | +$2.66M | ﹤0.01% | 3142 |
|
|
2019
Q3 | $985K | Buy |
13,139
+5,147
| +64% | +$380K | ﹤0.01% | 3655 |
|
|
2019
Q2 | $538K | Buy |
+7,992
| New | +$848K | ﹤0.01% | 3812 |
|
Other funds holding HOOK
KCM
JC
XT
Vanguard Group's HOOK Position: Q3 2025 in Review
Vanguard Group sold out of HOOKIPA Pharma (HOOK) in Q3 2025, closing a stake of 300,819 shares — an estimated $378K sold.
Vanguard Group first reported a position in HOOK in Q2 2019 and held it in 25 quarters. The position peaked at $12M in Q1 2021. 6 funds tracked by Wall St. Rank hold HOOK as of Q3 2025.
- Vanguard Group reported no remaining HOOKIPA Pharma position as of Q3 2025 after selling out during the quarter.
- Vanguard Group sold 300,819 HOOKIPA Pharma shares in Q3 2025, an estimated $378K.
- Vanguard Group first reported a position in HOOKIPA Pharma in Q2 2019 and held it in 25 quarters.
- Vanguard Group's HOOKIPA Pharma position peaked at $12M in Q1 2021.
- 6 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q3 2025.
Based on Vanguard Group's 13F filing for Q3 2025, filed 7 Nov 2025.